Genomics professionals write variant annotation reports, sequencing protocols, and FDA submissions where technical accuracy determines diagnostic validity. These documents require mastery of HGVS nomenclature, ACMG guidelines, and complex bioinformatics terminology that directly impacts patient care.

Our assessments evaluate candidates' ability to handle next-generation sequencing documentation, pharmacogenomics reporting, and regulatory compliance writing. The test predicts job performance by measuring precision with variant classifications, biomarker descriptions, and clinical genomics terminology.

Illustrative scenario

Variant Classification Error Delays Diagnostic Platform Launch

A genomics company's technical writer incorrectly classified pathogenic variants as likely pathogenic in FDA submission documents, conflating ACMG guidelines with internal scoring systems. The regulatory delay cost the company six months and $2.3 million in additional clinical validation studies.

A composite example of a failure mode that is common in Genomics. It is not an account of a real client engagement and no real organisation is described.

Documents You'll Be Testing

Variant Annotation Reports
Sequencing Protocol SOPs
GWAS Analysis Summaries
FDA Regulatory Submissions
Bioinformatics Pipeline Documentation
Clinical Trial Protocols

Avoid These Common Editorial Mistakes

Confusing pathogenic with likely pathogenic variants

Incorrect clinical recommendations and potential patient harm

Misrepresenting allele frequencies across populations

Biased diagnostic interpretations and health disparities

Incorrect HGVS variant nomenclature

Database submission failures and clinical miscommunication

Conflating whole genome with whole exome sequencing

Inappropriate test ordering and coverage gaps

Misusing polygenic risk score terminology

Patient confusion and inappropriate clinical actions

Master These Key Terms

Pathogenic vs Likely pathogenic
Whole genome sequencing vs Whole exome sequencing
Germline variant vs Somatic variant
Copy number variation vs Structural variant
Pharmacogenomics vs Pharmacogenetics

Smart Hiring Strategies

Prioritize candidates who demonstrate fluency with HGVS nomenclature, ACMG variant classification, and FDA genomics guidance documents. Look for experience distinguishing whole genome from targeted sequencing approaches and clear communication of complex bioinformatics workflows.

Genomics writing errors can lead to misdiagnosed genetic conditions, failed regulatory submissions, and compromised personalized medicine programs. Precise terminology and clear methodology descriptions are essential for patient safety and regulatory compliance in this rapidly evolving field.

Frequently Asked Questions

How do I know if candidates understand the difference between diagnostic and research-grade genomic testing? ↓
Test their knowledge of CLIA compliance requirements, clinical-grade variant interpretation standards, and FDA-approved diagnostic panels. Candidates should distinguish between research discoveries and clinically actionable findings.
What level of bioinformatics knowledge should genomics writers have? ↓
They need to understand basic pipeline concepts like variant calling, quality filtering, and annotation processes without necessarily writing code. Focus on their ability to clearly explain computational workflows and quality metrics.
Should I test candidates on specific sequencing platform terminology? ↓
Yes, test familiarity with major platforms like Illumina, PacBio, and Oxford Nanopore, as each has distinct technical specifications and applications. Candidates should understand when different technologies are appropriate.
How important is knowledge of population genetics for genomics writers? ↓
Very important, as they must accurately describe allele frequencies, ancestry considerations, and population stratification effects. Misrepresenting population data can perpetuate health disparities and bias diagnostic interpretations.
What regulatory knowledge should genomics candidates demonstrate? ↓
Test understanding of FDA guidance for companion diagnostics, CLIA laboratory standards, and international harmonization requirements. They should know the difference between laboratory-developed tests and FDA-approved diagnostics.